DK1576187T3 - Fremgangsmåde til bestemmelse af mængden af cirkulerende DNA i plasma samt påvisning af cancer - Google Patents
Fremgangsmåde til bestemmelse af mængden af cirkulerende DNA i plasma samt påvisning af cancerInfo
- Publication number
- DK1576187T3 DK1576187T3 DK03785912T DK03785912T DK1576187T3 DK 1576187 T3 DK1576187 T3 DK 1576187T3 DK 03785912 T DK03785912 T DK 03785912T DK 03785912 T DK03785912 T DK 03785912T DK 1576187 T3 DK1576187 T3 DK 1576187T3
- Authority
- DK
- Denmark
- Prior art keywords
- cancer
- plasma
- determining
- detection
- amount
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 5
- 201000011510 cancer Diseases 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000013399 early diagnosis Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT002743A ITMI20022743A1 (it) | 2002-12-23 | 2002-12-23 | Metodo per la determinazione del rischio di comparsa, della presenza o del decorso di malattie tumorali. |
| PCT/EP2003/014719 WO2004057024A1 (en) | 2002-12-23 | 2003-12-22 | Method for the detection of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1576187T3 true DK1576187T3 (da) | 2010-01-11 |
Family
ID=32676859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03785912T DK1576187T3 (da) | 2002-12-23 | 2003-12-22 | Fremgangsmåde til bestemmelse af mængden af cirkulerende DNA i plasma samt påvisning af cancer |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7888008B2 (da) |
| EP (1) | EP1576187B1 (da) |
| AT (1) | ATE442456T1 (da) |
| AU (1) | AU2003294932A1 (da) |
| DE (1) | DE60329224D1 (da) |
| DK (1) | DK1576187T3 (da) |
| ES (1) | ES2332716T3 (da) |
| IT (1) | ITMI20022743A1 (da) |
| WO (1) | WO2004057024A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2313143T3 (es) * | 2005-04-06 | 2009-03-01 | Maurice Stroun | Metodo para el diagnostico de cancer mediante la deteccion de adn y arn circulantes. |
| CN104593505A (zh) * | 2015-01-23 | 2015-05-06 | 上海迪安医学检验所有限公司 | 一种检测全血或血清样品中端粒酶的活性程度的试剂盒 |
| JP7239973B2 (ja) * | 2017-12-19 | 2023-03-15 | 国立大学法人山口大学 | 前癌病変又は癌の有無の予測を補助する方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6156504A (en) * | 1996-03-15 | 2000-12-05 | The Penn State Research Foundation | Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
| US6475789B1 (en) * | 1996-10-01 | 2002-11-05 | University Technology Corporation | Human telomerase catalytic subunit: diagnostic and therapeutic methods |
| WO1999041406A1 (en) | 1998-02-16 | 1999-08-19 | University Of Maryland, Baltimore | Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis |
| US7160996B1 (en) * | 1999-06-09 | 2007-01-09 | Bioresearch Technologies, Inc. | Fluorescence energy transfer probes with stabilized conformations |
| US6664046B1 (en) * | 1999-12-16 | 2003-12-16 | Roche Molecular Systems, Inc. | Quantitation of hTERT mRNA expression |
| EP1158055A1 (fr) * | 2000-05-26 | 2001-11-28 | Xu Qi University of Teaxs Laboratoire de Leucémie Chen | Méthode pour le diagnostic de cancers |
-
2002
- 2002-12-23 IT IT002743A patent/ITMI20022743A1/it unknown
-
2003
- 2003-12-22 EP EP03785912A patent/EP1576187B1/en not_active Expired - Lifetime
- 2003-12-22 ES ES03785912T patent/ES2332716T3/es not_active Expired - Lifetime
- 2003-12-22 US US10/538,495 patent/US7888008B2/en not_active Expired - Fee Related
- 2003-12-22 DK DK03785912T patent/DK1576187T3/da active
- 2003-12-22 WO PCT/EP2003/014719 patent/WO2004057024A1/en not_active Ceased
- 2003-12-22 AU AU2003294932A patent/AU2003294932A1/en not_active Abandoned
- 2003-12-22 DE DE60329224T patent/DE60329224D1/de not_active Expired - Lifetime
- 2003-12-22 AT AT03785912T patent/ATE442456T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US7888008B2 (en) | 2011-02-15 |
| EP1576187B1 (en) | 2009-09-09 |
| US20070148644A1 (en) | 2007-06-28 |
| EP1576187A1 (en) | 2005-09-21 |
| ATE442456T1 (de) | 2009-09-15 |
| AU2003294932A1 (en) | 2004-07-14 |
| DE60329224D1 (de) | 2009-10-22 |
| WO2004057024A1 (en) | 2004-07-08 |
| ITMI20022743A1 (it) | 2004-06-24 |
| ES2332716T3 (es) | 2010-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hourigan et al. | Measurable residual disease testing in acute myeloid leukaemia | |
| Eminler et al. | AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients | |
| DK1071710T4 (da) | Genomisk sekvens for 5-lipoxygenase-aktiveringsproteinet (FLAP), polymorfe markører deri og fremgangsmåder til påvisning af astma | |
| DK1342794T3 (da) | Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker | |
| GB0712154D0 (en) | Method for evaluating correlations between structured and normalized information on genetic variations between humans and their personal clinical patient data | |
| DK2848938T3 (da) | Evaluering af effektiviteten af en behandling hos et individ baseret på st2- niveauer | |
| WO2004030511A3 (en) | Prostate cancer biomarkers | |
| EP2293209A3 (en) | Method and apparatus for detecting and predicting biological anomalies and cerebral disorders | |
| WO2008140463A3 (en) | Biomarker panels for assessing radiation injury and exposure | |
| ATE406575T1 (de) | Verfahren zur erkennung von medikamentenempfindlichkeit in patienten mit entzündungskrankheiten | |
| DE60239470D1 (de) | Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna | |
| AU2003263834A8 (en) | Mutations in nod2 are associated with fibrostenosing disease in patients with crohn's disease | |
| EP2494922A3 (en) | Processing analyte sensor data | |
| WO2002061659A3 (en) | Computer-assisted means for assessing lifestyle risk factors | |
| BRPI0506752A (pt) | sistema ou método para avaliar a circulação de sangue periférica de um indivìduo | |
| ATE555430T1 (de) | Systeme und verfahren für computersicherheit | |
| PL1712639T3 (pl) | Sposób diagnozowania nowotworu przez wykrywanie krążącego DNA i RNA | |
| Maasoumy et al. | Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir | |
| Chen et al. | The relationship between the methylated septin‐9 DNA blood test and stool occult blood test for diagnosing colorectal cancer in Taiwanese people | |
| WO2012010871A3 (en) | Systems and methods for medical data processing and analysis | |
| ATE370414T1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| IL142971A0 (en) | S100 proteins and autoantibodies as serum markers for cancer | |
| WO2006015874A3 (en) | Method for diagnosing liver fibrosis | |
| FR2894046B1 (fr) | Procede de detection d'une erreur d'entree d'un des parametres de decollage dans un systeme de management de vol | |
| WO2009089296A3 (en) | Animal management |